Disease Burden and First-Line Melanoma Treatment

Panelists Keith T. Flaherty, MD; Georgina Long, BSc, MBBS; Jonathan S. Zager, MD; Jason J. Luke, MD; and Jeffrey S. Weber, MD, provide insight on the factors that impact initial choice of therapy in metastatic melanoma.